Peter Sagan repeats sprint to finish to take Stage 2 of the 2012 Amgen Tour of California
Picturesque Route Takes Cyclists from San Francisco and Down the Pacific Coast Before Ending in Santa Cruz County
APTOS, CALIF. (May 14, 2012) - Young Slovakian cycling sensation and overall 2012 Amgen Tour of California race leader Peter Sagan (SVK) of Liquigas-Cannondale crashed and punctured a tire on a wicked descent, but recovered to win Stage 2 of the race in Santa Cruz, Calif., his second consecutive stage in as many days. Ironically, the punctured tire was also the second flat of the race in as many days for the 22-year-old Sagan who maintained his overall lead over Australia's Heinrich Haussler of the Garmin-Barracuda team after the second stage of America's greatest professional cycling race. Leigh Howard (AUS) of Orica-GreenEDGE, who placed third during Stage 2, remained in third place overall.
"I don't know, maybe it takes a natural disaster," said Sagan, when asked what it would take to stop his winning ways, noting he suffered an untimely punctured tire three miles from the finish yesterday and still won Stage 1. "I am feeling good. I will see tomorrow (to make it three straight wins)," he continued.
Amidst breathtaking views of the San Francisco Bay, Golden Gate Bridge and Angel Island, Stage 2 of the 2012 Amgen Tour of California got underway in San Francisco and routed south 117.1 miles over the climbs of Empire Grade and Bear Creek Road.
At the start of Stage 2, after leaving the city of San Francisco, riders headed toward the coast and the first sprint of the day in Pacifica, where Howard, Maarten Tjallingii (NED) of Rabobank Cycling Team and Bradley White (USA) of UnitedHealthcare Pro Cycling Team were the first three to cross the line. Shortly thereafter, six racers, including White; Jeremy Vennell (NZL) of Bissell Pro Cycling; Michael Creed (USA) of Team Optum Powered by Kelly Benefit Strategies; Lloyd Mondory (FRA) of AG2R La Mondiale; Juan Pablo Suarez (COL) of Colombia-Coldeportes; and Alexandre Geniez (FRA) of Team Argos-Shimano established a breakaway. This breakaway swept the second sprint points with White, Vennell and Mondory crossing in that order.
Fifty miles into the race, the break had a comfortable lead of nine minutes and 45 seconds ahead of the peloton; however, after passing through the feed zone, the group began working harder to reel them back in. As the breakaway group closed in on Bonny Doon and the first King of the Mountain (KOM) climb of the day, the gap was narrowed to five minutes and 50 seconds. As the cyclists began to climb, Garmin-Barracuda worked hard at the front of the peloton for their leader Tom Danielson (USA). After a few attacks, only three riders were left in the break - White, Vennell and Geniez - with a lead of four minutes and 20 seconds. Sitting in and out of the saddle while climbing, Geniez went out in front of the break alone.
While on the climb, a crash occurred, taking down several riders, including Sagan; George Hincapie (USA) of BMC Racing Team; Laurens Ten Dam (NED) of Rabobank Cycling Team; Andres Diaz Corrales (COL) of Exergy; and Josh Atkins (NZL) of the Bontrager Livestrong Team. Sagan showed what he is made of by getting up quickly from the crash, brushing himself off and regaining contact with the peloton. While this was happening, Geniez continued to ride alone at the front with a lead of four minutes and 55 seconds ahead of the group, and ultimately claimed top KOM points on Empire Grade. He was followed by David Boily (CAN) of Spidertech Powered by C10.
With five riders at the front of the peloton, Garmin-Barracuda began flying down the mountain with a gap of three minutes and 55 seconds off the front. Vennell and White hung together, in between Geniez and the peloton. After the decent, the peloton was split with about 25 racers in the first portion, then about a 30-second split to the main peloton. Just before the Bear Creek climb, Vennell and White were absorbed by the peloton, leaving Geniez alone in front. But, with just 35km to go, Geniez was caught by the peloton, which was being led by UnitedHealthcare Pro Cycling Team.
"It was a very hard day," said Vennell, a former National Time Trial champion of New Zealand. "The descent off Bonny Doon was pretty scary."
Liquigas-Cannondale took over work at the front of the peloton, controlling the pace on the last bit of uphill before the major descent. Heading toward the final sprint of the day, Maxime Bouet (FRA) of AG2R La Mondiale attacked, but Marc de Maar (AHO) of UnitedHealthcare Pro Cycling Team claimed the top sprint points. With 17km to go, the peloton was flying toward the finish with Liquigas-Cannondale riders occupying the top four spots at the front, followed by riders from Rabobank, BMC Racing Team and RadioShack-Nissan-Trek.
Even with an attack by Rory Sutherland (AUS) of UnitedHealthcare Pro Cycling Team at the finish, Sagan managed to outsprint the pack to take the Stage 2 win. He was followed by Haussler and Howard to round out the top three for the stage.
Leader jerseys at the end of Stage 2 remained somewhat similar to Stage 1, with Sagan remaining in the Amgen Race Leader, Visit California Sprint and Rabobank Best Young Rider Jerseys. As with yesterday, since Sagan will be wearing the Amgen Race Leader Jersey at the start of tomorrow's stage, the Visit California Sprint Jersey will be worn by Haussler and the Rabobank Best Young Rider Jersey will be worn by Atkins. Boily still wears the polka dot Nissan King of the Mountain jersey. Vennell claimed the Amgen Breakaway from Cancer® Most Courageous Rider Jersey, and Geniez secured the Exergy Most Aggressive Rider Jersey.
Today's Breakaway from Cancer activities featured cancer survivors and long-time Breakaway from Cancer supporters Blaine and Ellen Mauldin, husband and wife, who fired the official start gun together to begin the stage, and cancer survivor Marilyn Luma had the honor of awarding Vennell with the Amgen Breakaway from Cancer Most Courageous Rider jersey.
"Amgen wants patients and their caregivers, physicians, policymakers, and the public to better understand the contributions the biotechnology industry makes toward advances in medicine," said Stuart Arbuckle, vice president and general manager, Amgen Oncology. "That's why Amgen is proud to sponsor the Amgen Tour of California and to continue the Breakaway from Cancer® initiative as a vehicle to raise awareness of the important resources available to people affected by cancer - from prevention through survivorship."
Amgen created the national Breakaway from Cancer initiative in 2005 as a complementary component to its sponsorship of the inaugural Amgen Tour of California. Through Breakaway from Cancer, Amgen and its four nonprofit partners are dedicated to empowering patients with education, resources, and hope. For access to resources or to learn more, visit breakawayfromcancer.com.
STAGE 3 TOMORROW:Tuesday, May 15 - San Jose to Livermore (115.3 mi/185.5 km)
Start Time: 11:15 a.m. PT
Estimated Finish Time: 3:24 - 4:32 p.m. PT
Satellite Feed Time: 4:50 - 5 p.m. PT
(Coordinates can be found at http://www.amgentourofcalifornia.com/news/media-info.html)
Stage 3 will begin in San Jose, the only city to have played host to the Amgen Tour of California all seven years of the race. This year, the typical downtown start has been moved to north San Jose, just a few miles from the infamous Sierra Road climb. While the riders won't be expected to tackle a Category 1 climb just two miles from the start as they have been in the past, the route into Livermore is one that the race has taken before: Calaveras Road and Highway 84.
While Livermore will be hosting their first stage finish in 2012, riders have raced through the town during previous editions including the Stage 4 start in 2011.
Just 28 miles into the race, the riders will contest a challenging sprint to the finish but the race will just be getting started. Heading out north on Livermore Avenue, the riders will likely face a stiff headwind coming down the valley. After passing through the town of Danville, the riders will climb Mt. Diablo for the first time in the history of the race. One of the most revered climbs in California, race organizers, cyclists and fans alike are excited to have this climb as part of Stage 3 of the 2012 race.
After a fast and technical descent into Walnut Creek, the race will then head east into the Town of Clayton where the second sprint of the stage will take place. From Clayton, the race will connect back to a familiar route into Livermore. Just nine miles from the finish, the riders will likely tackle blustery winds as they battle the final KOM of the stage up Patterson Pass Road followed by a quick descent that will take the race onto Cross and Tesla roads. On Livermore Avenue once again, it will be just a few miles to what is sure to be a sprint finish in historic downtown Livermore. At tomorrow's finish line, Amgen will host one if its Breakaway Mile events, which will honor Livermore's Breakaway from Cancer Champion Bob Hammer, a cancer survivor who founded the "Have a Ball" Foundation, which has raised more than $1 million since its inception and benefits 20 cancer support organizations. The Breakaway Mile is slated to begin about an hour before the professional cyclists cross the finish line of Stage 3 of the Amgen Tour.
About the Amgen Tour of CaliforniaThe largest cycling event in America, the 2012 Amgen Tour of California is a Tour de France-style cycling road race, created and presented by AEG, that challenges the world's top professional cycling teams to compete along a demanding course from May 13-20, 2012.
About AmgenAmgen discovers, develops, manufactures, and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and vital medicines, visit http://www.amgen.com. Follow us on www.twitter.com/amgen.
About AEGAEG is one of the leading sports and entertainment presenters in the world. AEG, a wholly owned subsidiary of The Anschutz Company, owns or controls a collection of companies including facilities such as STAPLES Center, The Home Depot Center, Sprint Center, The O2, Nokia Theatre L.A. LIVE and Best Buy Theater Times Square; sports franchises including the Los Angeles Kings (NHL), two Major League Soccer franchises, two hockey franchises operated in Europe, management of privately held shares of the Los Angeles Lakers, the ING Bay to Breakers foot race, and the Amgen Tour of California cycling road race; AEG Live, the organization's live-entertainment division, is a collection of companies dedicated to all aspects of live contemporary music performance, touring, and a variety of programming and multi-media production. For more information, visit AEG today at www.aegworldwide.com.
619-347-3722 (cell; 5/10-5/20)